Myelodysplastic Syndromes News and Research

RSS
Epigenetic Key Unlocks Treatment Path for Endocrine-Resistant Breast Cancer

Epigenetic Key Unlocks Treatment Path for Endocrine-Resistant Breast Cancer

Wilmot Researchers Uncover a "Genomic Tug of War" That Influences Decitabine's Effectiveness

Wilmot Researchers Uncover a "Genomic Tug of War" That Influences Decitabine's Effectiveness

Review: Role of Alternative Splicing Defects in Major Neurodegenerative Diseases

Review: Role of Alternative Splicing Defects in Major Neurodegenerative Diseases

Revealing the functional significance of DDX41 in great detail

Revealing the functional significance of DDX41 in great detail

Two distinct classes of stem cells drive treatment resistance in patients with myelodysplastic syndromes

Two distinct classes of stem cells drive treatment resistance in patients with myelodysplastic syndromes

Molecular landscape of myelodysplastic/myeloproliferative neoplasms revealed

Molecular landscape of myelodysplastic/myeloproliferative neoplasms revealed

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.